256 related articles for article (PubMed ID: 16150649)
1. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.
Ohlfest JR; Demorest ZL; Motooka Y; Vengco I; Oh S; Chen E; Scappaticci FA; Saplis RJ; Ekker SC; Low WC; Freese AB; Largaespada DA
Mol Ther; 2005 Nov; 12(5):778-88. PubMed ID: 16150649
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System.
Belur LR; Podetz-Pedersen KM; Sorenson BS; Hsu AH; Parker JB; Carlson CS; Saltzman DA; Ramakrishnan S; McIvor RS
Mol Cancer; 2011 Feb; 10(1):14. PubMed ID: 21310067
[TBL] [Abstract][Full Text] [Related]
3. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
4. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
[TBL] [Abstract][Full Text] [Related]
7. A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.
Frau E; Magnon C; Opolon P; Connault E; Opolon D; Beermann F; Abitbol M; Perricaudet M; Bouquet C
Cancer Gene Ther; 2007 Mar; 14(3):251-61. PubMed ID: 17082795
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts.
Zhang G; Jin G; Nie X; Mi R; Zhu G; Jia W; Liu F
PLoS One; 2014; 9(4):e95872. PubMed ID: 24755877
[TBL] [Abstract][Full Text] [Related]
10. Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.
Szentirmai O; Baker CH; Bullain SS; Lin N; Takahashi M; Folkman J; Mulligan RC; Carter BS
J Neurosurg; 2008 May; 108(5):979-88. PubMed ID: 18447716
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method.
Kim KS; Park YS
Oncol Res; 2005; 15(7-8):343-50. PubMed ID: 16491952
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin.
De Boüard S; Guillamo JS; Christov C; Lefévre N; Brugières P; Gola E; Devanz P; Indraccolo S; Peschanski M
Hum Gene Ther; 2003 Jun; 14(9):883-95. PubMed ID: 12828859
[TBL] [Abstract][Full Text] [Related]
13. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.
Schmidt NO; Ziu M; Carrabba G; Giussani C; Bello L; Sun Y; Schmidt K; Albert M; Black PM; Carroll RS
Clin Cancer Res; 2004 Feb; 10(4):1255-62. PubMed ID: 14977823
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.
Sun X; Qiao H; Jiang H; Zhi X; Liu F; Wang J; Liu M; Dong D; Kanwar JR; Xu R; Krissansen GW
Cancer Gene Ther; 2005 Jan; 12(1):35-45. PubMed ID: 15486558
[TBL] [Abstract][Full Text] [Related]
17. Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy.
Luo WY; Shih YS; Hung CL; Lo KW; Chiang CS; Lo WH; Huang SF; Wang SC; Yu CF; Chien CH; Hu YC
Gene Ther; 2012 Aug; 19(8):844-51. PubMed ID: 21918552
[TBL] [Abstract][Full Text] [Related]
18. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
19. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
